EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
Lotte Group Chairman Shin Dong-bin is seeking ways to strengthen corporate competitiveness amid the global economic downturn, according to the company, Thursday. Lotte held the 2023 Lotte Value Creation Meeting (VCM), at Lotte World Tower in Seoul, Thursday, and discussed group management plans and medium- to long-term strategies as global market volatility and uncertainty are on the rise.
Lotte Biologics, a pharmaceutical unit under the retail giant Lotte Group, said Wednesday it will invest $3 billion to build a bio industrial complex in Korea by 2030 that houses three plants.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
Lotte Biologics, a biopharmaceutical affiliate of Lotte Group, said Tuesday that on Dec. 31 it acquired a manufacturing plant of its New York Stock Exchange-listed peer, Bristol Myers Squibb in East Syracuse, New York.